What are the concerns when combining ceremonial cacao with sertraline (selective serotonin reuptake inhibitor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceremonial Cacao and Sertraline: Potential Interaction Concerns

Ceremonial cacao should be used with caution when combined with sertraline due to the risk of serotonin syndrome, a potentially life-threatening condition caused by excessive serotonergic activity. 1

Mechanism of Interaction

Ceremonial cacao contains compounds that may interact with sertraline through several mechanisms:

  • Cacao contains various bioactive compounds including:

    • Theobromine (a stimulant)
    • Caffeine (albeit in small amounts)
    • Phenylethylamine (PEA)
    • Various flavonoids and other compounds
  • Sertraline is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain 1

  • The combination may potentially increase serotonergic activity through additive effects

Specific Concerns

1. Risk of Serotonin Syndrome

Serotonin syndrome is characterized by a triad of symptoms 1, 2:

  • Mental status changes (agitation, confusion)
  • Neuromuscular abnormalities (tremor, hyperreflexia, clonus)
  • Autonomic instability (hyperthermia, tachycardia, diaphoresis)

Even sertraline monotherapy has been reported to cause serotonin syndrome in rare cases 3, suggesting that adding other serotonergic substances could increase this risk.

2. Pharmacokinetic Interactions

  • Compounds in cacao may affect the metabolism of sertraline through the cytochrome P450 system
  • This could potentially alter sertraline blood levels and increase the risk of side effects 4

3. Cardiovascular Effects

  • Both substances can affect cardiovascular parameters
  • Sertraline can cause side effects including dizziness and headache 5
  • Cacao contains stimulants that may compound these effects

Monitoring Recommendations

If a patient chooses to consume ceremonial cacao while taking sertraline:

  1. Start with very small amounts of ceremonial cacao to assess tolerance

  2. Monitor for early signs of serotonin syndrome, which typically develops within 24-48 hours 1:

    • Tremor
    • Agitation
    • Diaphoresis
    • Hyperreflexia
    • Clonus
    • Elevated temperature
  3. Discontinue ceremonial cacao immediately if any concerning symptoms develop

Management of Adverse Effects

If serotonin syndrome is suspected:

  1. Discontinue both sertraline and ceremonial cacao immediately
  2. Seek emergency medical attention
  3. Treatment may include:
    • Benzodiazepines for agitation
    • Management of hyperthermia
    • IV fluids for autonomic instability
    • Serotonin antagonists such as cyproheptadine in severe cases 1

Important Caveats

  • Individual sensitivity varies greatly - some patients may tolerate the combination while others may experience adverse effects
  • The dose of ceremonial cacao matters - higher doses increase risk
  • Frequency of consumption affects risk - daily use poses greater concerns than occasional use
  • Pre-existing conditions, especially cardiovascular issues, may increase risk

While limited research exists specifically on cacao-sertraline interactions, the potential for serotonin syndrome with combinations of serotonergic substances is well-documented 6, 7. The safest approach is to use ceremonial cacao with extreme caution, if at all, while taking sertraline.

References

Guideline

Serotonin Syndrome Prevention and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serotonin syndrome from sertraline monotherapy.

The American journal of emergency medicine, 2020

Research

Multiple drug interactions - induced serotonin syndrome: a case report.

Journal of clinical pharmacy and therapeutics, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.